MHRA Guidance: Pre-submission Advice & Support

Last updated: 1 October 2024

To view updates, click on the ‘+’ sign below.

DateUpdate(s)
1 Oct 2024MHRA has today posted the following update on its website:

Information on the webpage has been updated, along with the latest version of the Pre-submission Notification Form.

New section For ACCESS and Orbis procedures has been added.

The UK MHRA offers a pre-submission service before applying for medicines Marketing Authorisations.

  • This service aims to provide the best support possible for prospective applicants, whichever application route is chosen.
  • Pre-submission advice is a service that provides stakeholders with the means to understand how the process of compiling and submitting applications and supporting evidence applies for their product/s. It is distinct from MHRAs Scientific Advice offering.
  • The relevant forms (below) can be downloaded, filled in and returned to presubmission@mhra.gov.uk where one of the team will triage these to the relevant area.
For International recognition
For New Active Substances and/or complex applications
  • Companies intending to submit Marketing Authorisation Applications for New Active Substances and/or Biological products must request a pre-submission meeting with the relevant teams at-least 3 months prior to the intended application date.
  • This can be done by downloading the Pre-submission Advice Form completing and and returning it to presubmission@mhra.gov.uk.
  • If there are any questions or queries on the above document/s and process, please direct these to presubmission@mhra.gov.uk.
For ACCESS and Orbis procedures

Applicants intending to submit Marketing Authorisation Applications for New Active Substances and/or Biological products or applications for new indications through the ACCESS work sharing initiative or the project ORBIS procedure, must also notify the relevant teams via the pages below:

Access Consortium – GOV.UK (www.gov.uk)

Project Orbis – GOV.UK (www.gov.uk)

If there are any questions or queries on the above document/s and process, please direct these to presubmission@mhra.gov.uk.

Source: MHRA